Gameto is a biotechnology company translating the impact of ovarian aging to develop solutions to improve fertility and stop the impact of menopause on female health.

Gameto's scientific work involves reconstituting ovarian development and function in vitro, elucidating the underlying growth factor and genetic networks that drive human ovarian development and oogenesis. We aim to leverage our allogeneic human cellular derivatives of our platform to therapeutic applications for assisted fertility and menopause.

• Industry

  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2021

• Founders

  • Dr. Dina Radenkovic
  • Martin Varsavsky

  LUX Partners

  • Deena Shakir

• Latest Tweets

  • 📢 HIRING📢 Are you looking for a role at the forefront of #longevity #biotech? Join us for a virtual job fair on… https://t.co/ulywIHsjkn@GametoGen - 04:10 PM Jan 14th
  • Gameto brings together people who are #scientists, creative problem-solvers, resilient executors & are intensely pa… https://t.co/2cyyQibULV@GametoGen - 04:32 PM Jan 13th
  • Some of the women who backed Gameto have their own stories to tell about nature being sexist. Special thanks to mem… https://t.co/RAUHoHyZNw@GametoGen - 07:26 PM Jan 12th